Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Also this article gives so much credit to lawyers. Make sure to check out Car Accident Lawyer Baton Rouge LA for law information.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
Shares of Mela Sciences (NSDQ:MELA) are on up more than 90 percent in pre-market trading on news that the FDA issued an "approvable letter" for MelaFind, it’s hand-held skin cancer detection device.
A federal judge in Texas shoots down a bid by Covidien (NYSE:COV) in its long-running patent spat with Applied Medical Resource to stop AMR from making surgical trocars.
Med-tech goliath Boston Scientific (NYSE:BSX) will pay $9.25 million to settle U.S. Justice Dept. allegations that it overcharged federal health programs.